Nicole Lawrence

Dr. Nicole Lawrence

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
FVFelicitas Vernen
Felicitas Vernen
PHPeta Harvey
Peta Harvey
SDSusana Dias
Susana Dias
AVAna Salomé Veiga
Ana Salomé Veiga
YHYen-Hua Huang
Yen-Hua Huang
SHSonia Troeira Henriques
Sonia Troeira Henriques
Tachyplesin I, II and III are host defense peptides from horseshoe crab species with antimicrobial and anticancer activities. They have an amphipathic β-hairpin structure, are highly positively-charged and differ by only one or two amino acid residues. In this study, we compared the structure and activity of the three tachyplesin peptides alongside their backbone cyclized analogues. We assessed the peptide structures using nuclear magnetic resonance (NMR) spectroscopy, then compared the activity against bacteria (both in the planktonic and biofilm forms) and a panel of cancerous cells. The importance of peptide-lipid interactions was examined using surface plasmon resonance and fluorescence spectroscopy methodologies. Our studies showed that tachyplesin peptides and their cyclic analogues were most potent against Gram-negative bacteria and melanoma cell lines, and showed a preference for binding to negatively-charged lipid membranes. Backbone cyclization did not improve potency, but improved peptide stability in human serum and reduced toxicity toward human red blood cells. Peptide-lipid binding affinity, orientation within the membrane, and ability to disrupt lipid bilayers differed between the cyclized peptide and the parent counterpart. We show that tachyplesin peptides and cyclized analogues have similarly potent antimicrobial and anticancer properties, but that backbone cyclization improves their stability and therapeutic potential.

1 August 2016 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SHSonia Troeira Henriques
Sonia Troeira Henriques
Evelyne DeplazesEvelyne Deplazes
Evelyne Deplazes
NLNicole Lawrence
Nicole Lawrence
OCOlivier Cheneval
Olivier Cheneval
SCStephanie Chaousis
Stephanie Chaousis
Christina I SchroederChristina I Schroeder
Christina I Schroeder
ProTx-II is a disulfide-rich peptide toxin from tarantula venom able to inhibit the human voltage-gated sodium channel 1.7 (hNaV1.7), a channel reported to be involved in nociception, and thus it might have potential as a pain therapeutic. ProTx-II acts by binding to the membrane-embedded voltage sensor domain of hNaV1.7, but the precise peptide channel-binding site and the importance of membrane binding on the inhibitory activity of ProTx-II remain unknown. In this study, we examined the structure and membrane-binding properties of ProTx-II and several analogues using NMR spectroscopy, surface plasmon resonance, fluorescence spectroscopy, and molecular dynamics simulations. Our results show a direct correlation between ProTx-II membrane binding affinity and its potency as an hNaV1.7 channel inhibitor. The data support a model whereby a hydrophobic patch on the ProTx-II surface anchors the molecule at the cell surface in a position that optimizes interaction of the peptide with the binding site on the voltage sensor domain. This is the first study to demonstrate that binding of ProTx-II to the lipid membrane is directly linked to its potency as an hNaV1.7 channel inhibitor.

8 August 2017 in ACS Chemical Biology
Verified
Journal Article
Closed access
SHSonia Troeira Henriques
Sonia Troeira Henriques
NLNicole Lawrence
Nicole Lawrence
SCStephanie Chaousis
Stephanie Chaousis
ARAnjaneya S. Ravipati
Anjaneya S. Ravipati
OCOlivier Cheneval
Olivier Cheneval
DCDavid Craik
David Craik

1 May 2017 in Biochimica et Biophysica Acta (BBA) - Biomembranes
Verified
Journal Article
Closed access
AAAkello J. Agwa
Akello J. Agwa
NLNicole Lawrence
Nicole Lawrence
Evelyne DeplazesEvelyne Deplazes
Evelyne Deplazes
OCOlivier Cheneval
Olivier Cheneval
RCRachel M. Chen
Rachel M. Chen
SHSonia Troeira Henriques
Sonia Troeira Henriques

1 June 2018 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
AAAkello J. Agwa
Akello J. Agwa
SPSteve Peigneur
Steve Peigneur
CYChow Chun Yuen
Chow Chun Yuen
NLNicole Lawrence
Nicole Lawrence
DCDavid J. Craik
David J. Craik
Christina I SchroederChristina I Schroeder
Christina I Schroeder
Gating modifier toxins (GMTs) are venom-derived peptides isolated from spiders and other venomous creatures that modulate activity of disease-relevant voltage-gated ion channels and are therefore being pursued as therapeutic leads. The amphipathic surface profile of GMTs has prompted the proposal that some GMTs simultaneously bind to the cell membrane and voltage-gated ion channels in a trimolecular complex. Here we examined whether there is a relationship among spider GMT amphipathicity, membrane binding and potency or selectivity for voltage-gated sodium (NaV) channels. We used NMR spectroscopy and in silico calculations to examine the structures and physicochemical properties of a panel of nine GMTs and deployed surface plasmon resonance to measure GMT affinity for lipids putatively found in proximity to NaV channels. Electrophysiology was used to quantify GMT activity on NaV1.7, an ion channel linked to chronic pain. Selectivity of the peptides was further examined against a panel of NaV channel subtypes. We show that GMTs adsorb to the outer leaflet of anionic lipid bilayers through electrostatic interactions. We did not observe a direct correlation between GMT amphipathicity and affinity for lipid bilayers. Furthermore, GMT–lipid bilayer interactions did not correlate with potency or selectivity for NaVs. We therefore propose that increased membrane binding is unlikely to improve subtype selectivity and that the conserved amphipathic GMT surface profile is an adaptation that facilitates simultaneous modulation of multiple NaVs.

10 June 2016 in Peptide Science
Verified
Journal Article
Closed access
PDF file
GPGrégoire Philippe
Grégoire Philippe
YHYen-Hua Huang
Yen-Hua Huang
OCOlivier Cheneval
Olivier Cheneval
NLNicole Lawrence
Nicole Lawrence
ZZZhen Zhang
Zhen Zhang
SHSonia Troeira Henriques
Sonia Troeira Henriques